The jab – currently known as ChAdOx1 biEBOV – uses the same technology as the breakthrough coronavirus shot.
It has been designed to tackle the Zaire and Sudan strains of Ebola, the two most common and deadly types. The Daily Mail
See also:
Thursday, 11 November 2021
New Ebola vaccine made by team behind Oxford/AstraZeneca Covid vaccine starts human trials
New Ebola vaccine made by team behind Oxford/AstraZeneca Covid vaccine starts human trials A new Ebola vaccine that was developed by the Oxford University team that made the AstraZeneca Covid jab is being trialled in humans for the first time today.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment